| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jan―15 |
Blood biomarkers: a new solution to the silent pandemic of traumatic brain injury |
Charalampos Tsakiris, Timoleon Siempis, Georgios D Lianos, Labrini Vlachodimitropoulou, Spyridon Voulgaris, George A Alexiou |
| 2 |
[GO] |
2023―Aug―31 |
Differential absolute plasma IL-6 concentrations between two immunoassay platforms in intensive care unit patients with COVID-19 |
Pavan K Bhatraju, Eric D Morrell, Nicholas G O'Connor, Audrey Choi, Michael Fitzpatrick, Craig H Smith, Mark M Wurfel, Wayne Conrad Liles |
| 3 |
[GO] |
2023―Jun―20 |
Association between the copper/selenium ratio and the immune response to SARS-CoV-2 infection |
Mahnaz Tashakori, Ahmad Jamalizadeh, Mohsen Nejad-Ghaderi, Maryam Hadavi, Aliakbar Yousefi-Ahmadipour, Fatemeh M Moghadam, Maryam Rahnama, Saeed M Haftcheshmeh, Kazem Mashayekhi, Amir A Momtazi-Borojeni |
| 4 |
[GO] |
2023―Apr―11 |
Comparison of thromboembolic risk scores for evaluating in-hospital events of COVID-19 patients |
Ömer Genç, Abdullah Yildirim, Mürşide Genç, Fahri Er, Gökhan Alici, Alaa Quisi, Hazar Harbalioğlu, Samir Allahverdiyev, İbrahim H Kurt |
| 5 |
[GO] |
2022―Sep―13 |
Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19 |
Serap Biberoğlu, Afşin İpekci, İbrahim İkizceli, Fatih Çakmak, Yonca S Akdeniz, Altuğ Kanbakan, Dildar Konukoğlu, İbrahim M Bolayırlı, Şermin Börekçi, Seval Ürkmez, Seda Özkan |
| 6 |
[GO] |
2022―Sep―02 |
Changes in lactate dehydrogenase on admission throughout the COVID-19 pandemic and possible impacts on prognostic capability |
Elba O Medina-Hernández, Lucía M Pérez-Navarro, Joselín Hernández-Ruiz, Alma Villalobos-Osnaya, María L Hernández-Medel, Catalina Casillas-Suárez, Adolfo Pérez-García |
| 7 |
[GO] |
2022―Sep―02 |
Prognostic value of heparin-binding protein for mortality in severe COVID-19 pneumonia |
Tarık Acar, Birsen Ertekin, Mehmet Yortanlı, Sedat Koçak |
| 8 |
[GO] |
2022―Aug―25 |
What is the role of prognostic indexes in COVID-19 patients with diabetes mellitus? Data of patients from Turkey |
Safak O Balin, Ulku Kazanci, Kutbeddin Demirdag, Ayhan Akbulut |
| 9 |
[GO] |
2022―Jul―14 |
Is there a relationship between epicardial adipose tissue, inflammatory markers and prognosis in COVID-19 in patients under 65 years? |
Emre Emekli, Mustafa H Türkkanı, Sevgi S Ballı |
| 10 |
[GO] |
2022―Jul―05 |
Association between D-dimer levels and post-acute sequelae of SARS-CoV-2 in patients from a tertiary care center |
MK Kalaivani, Shanthi Dinakar |
| 11 |
[GO] |
2022―Jun―13 |
Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection |
Pamila Dua, Archana Mishra, KH Reeta |
| 12 |
[GO] |
2022―May―16 |
Serum hemato-immunological biomarkers associated with increased COVID-19 mortality in the Latino population |
Carla PS Ríos, Oscar GJ Cabrera, Juan JJ-V Whaley, Marisol D Sosa, Victor HA Palacios, Guadalupe LH González, José CJ López |
| 13 |
[GO] |
2022―May―09 |
Urinary tubular biomarkers as predictors of death in critically ill patients with COVID-19 |
Gabriela F Bezerra, Gdayllon C Meneses, Polianna LMM Albuquerque, Nicole C Lopes, Ranieri SS Santos, Juliana C da Silva, Sandra MB Mota, Rodrigo R Guimarães, Fábio R Guimarães, Álvaro R Guimarães, Caio MC Adamian, Paula R de Lima, Izabel CJ Bandeira, Márcia MP Dantas, Geraldo BS Junior, Reinaldo B Oriá, Elizabeth F Daher, Alice MC Martins |
| 14 |
[GO] |
2022―Mar―30 |
Novel biomarker-based score (SAD-60) for predicting mortality in patients with COVID-19 pneumonia: a multicenter retrospective cohort of 1013 patients |
Serkan Surme, Gulsah Tuncer, Osman F Bayramlar, Betul Copur, Esra Zerdali, Inci Y Nakir, Meltem Yazla, Ahmet Buyukyazgan, Ayse RK Cinar, Yesim Kurekci, Mustafa Alkan, Yusuf E Ozdemir, Gonul Sengoz, Filiz Pehlivanoglu |
| 15 |
[GO] |
2022―Mar―30 |
Copeptin: a neuroendocrine biomarker of COVID-19 severity |
Reham Hammad, Ahmed Elshafei, Emad Gamil Khidr, Ahmed A El-Husseiny, Maher H Gomaa, Hend G Kotb, Heba H Eltrawy, Hesham Farhoud |
| 16 |
[GO] |
2022―Mar―28 |
Homocysteine as a marker for predicting disease severity in patients with COVID-19 |
Adem Keskin, Goksenin U Ustun, Recai Aci, Utku Duran |
| 17 |
[GO] |
2022―Mar―02 |
Organ function biomarker abnormalities, associated factors and disease outcome among hospitalized patients with COVID-19 |
Shambel Araya, Yakob G Tsegay, Assegdew Atlaw, Mintsnot Aragaw, Getachew Tadlo, Nebiyu Tsegaye, Daniel Kahase, Zenebe Gebreyohanes, Mollalegne Bitew, Nega Berhane |
| 18 |
[GO] |
2022―Feb―23 |
Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients |
Ákos Nádasdi, György Sinkovits, Ilona Bobek, Botond Lakatos, Zsolt Förhécz, Zita Z Prohászka, Marienn Réti, Miklós Arató, Gellért Cseh, Tamás Masszi, Béla Merkely, Péter Ferdinandy, István Vályi-Nagy, Zoltán Prohászka, Gábor Firneisz |
| 19 |
[GO] |
2022―Feb―18 |
Biomarker evaluation for prognostic stratification of patients with COVID-19: the added value of quantitative chest CT |
Roberto M Ferreira, Gabriel SS de Oliveira, João RF da Rocha, Felipe de MC Ribeiro, João J Stern, Rangel de S Costa, Ricardo N Lemgruber, Júlia FP Ramalho, Alexandre CP de Almeida, Pedro PN Sampaio, João Mansur Filho, Ricardo AC Lima |
| 20 |
[GO] |
2022―Jan―27 |
Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients |
Mael Padelli, Papa Gueye, Diane Guilloux, Rishika Banydeen, Valentine Campana, Andre Cabie, Remi Neviere |
| 21 |
[GO] |
2021―Nov―17 |
Prognostic Nutritional Index and CRP, age, platelet count, albumin level score in predicting mortality and intensive care unit admission for COVID-19 |
Mehmet Bayram, Ozgur Yildirim, Raye S Ozmen, Beyza Soylu, Ahmet S Dundar, Ali R Koksal, Iskender Ekinci, Murat Akarsu, Omur Tabak |
| 22 |
[GO] |
2021―Nov―17 |
Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field |
Marília B Visacri, Aline de S Nicoletti, Eder de C Pincinato, Pía Loren, Nicolás Saavedra, Kathleen Saavedra, Luis A Salazar, Patricia Moriel |
| 23 |
[GO] |
2021―Oct―20 |
Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19 |
Selda Murat, Bektas Murat, Muhammet Dural, Gurbet Ozge Mert, Yuksel Cavusoglu |
| 24 |
[GO] |
2021―Oct―20 |
Plasma endostatin correlates with hypoxia and mortality in COVID-19-associated acute respiratory failure |
Sana Asif, Thoralph Ruge, Anders Larsson, Sara Bülow Anderberg, Miklos Lipcsey, Robert Fritiof, Michael Hultström |
| 25 |
[GO] |
2021―Sep―20 |
Prospective selected biomarkers in COVID-19 diagnosis and treatment |
Tahani Tabassum, Ahsab Rahman, Yusha Araf, Md A Ullah, Mohammad J Hosen |
| 26 |
[GO] |
2021―Sep―02 |
Emerging treatments for COVID-19: déjà vu all over again? |
Ricardo AC Lima, Roberto M Ferreira |
| 27 |
[GO] |
2021―Aug―18 |
Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS coronavirus-2 |
Saban Kelesoglu, Yucel Yilmaz, Eyup Ozkan, Bekir Calapkorur, Zehra B Dursun, Aysegul Ulu-Kilic, Deniz Elcık |
| 28 |
[GO] |
2021―Jul―21 |
National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-19 |
Gulsah Tuncer, Serkan Surme, Osman F Bayramlar, Hatice K Karanalbant, Betul Copur, Meltem Yazla, Esra Zerdali, Inci Y Nakir, Ayse RK Cinar, Ahmet Buyukyazgan, Hatice Balli, Yesim Kurekci, Serap Simsek-Yavuz, Mehmet M Sonmez, Gonul Sengoz, Filiz Pehlivanoglu |
| 29 |
[GO] |
2021―May―14 |
COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings |
Salvatore Fuschillo, Pasquale Ambrosino, Andrea Motta, Mauro Maniscalco |
| 30 |
[GO] |
2021―May―14 |
Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience |
Eman Farid, Kannan Sridharan, Ola AM Alsegai, Safa Al Khawaja, Eman J Mansoor, Noor A Teraifi, Manaf Al Qahtani, Jameela Al Salman |
| 31 |
[GO] |
2021―Mar―29 |
Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19 |
Zhikun Zeng, Xiao-Yue Hong, Yunhui Li, Wei Chen, Guangming Ye, Yirong Li, Yi Luo |
| 32 |
[GO] |
2021―Mar―05 |
Biomarkers to safely discharge head trauma patients in the COVID-19 pandemic era |
George A Alexiou, Georgios D Lianos, Eleftherios-Spyridon Alexiou, Spyridon Voulgaris |
| 33 |
[GO] |
2021―Jan―27 |
Evaluation of the relation between cardiac biomarkers and thorax computerized tomography findings in COVID-19 patients |
Cigdem Ileri, Zekeriya Dogan, Beste Ozben, Cagla Karaoglu, Nuran Gunay, Kursat Tigen, Sema Basat, Cihangir Uyan |
| 34 |
[GO] |
2020―Jul―21 |
The role of hematological parameters in COVID-19 patients in the emergency room |
Eren Usul, İshak Şan, Burak Bekgöz, Ali Şahin |
| 35 |
[GO] |
2020―Jul―17 |
The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort |
Shant Ayanian, Juan Reyes, Lei Lynn, Karolyn Teufel |
| 36 |
[GO] |
2020―Jun―03 |
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19 |
Juyi Li, Meng Li, Shasha Zheng, Menglan Li, Minghua Zhang, Minxian Sun, Xiang Li, Aiping Deng, Yi Cai, Hongmei Zhang |
| 37 |
[GO] |
2020―May―19 |
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis |
Nicola Ielapi, Noemi Licastro, Michele Provenzano, Michele Andreucci, Stefano de Franciscis, Raffaele Serra |
|
